NCT06075589Active, not recruiting
Psychoeducation for Uveal Melanoma
Promoting Adjustment in Uveal Melanoma Survivorship: A Randomized Trial Targeting Illness Perceptions
Source: ClinicalTrials.gov · Last updated 19 Mar 2026
Brief summary (registry, in English)
This clinical trial evaluates a video-based psychoeducational intervention for patients with uveal melanoma. Uveal melanoma (UM) is a rare intraocular cancer. UM patients face an uncertain course of survivorship in terms of their visual acuity, treatment-related side effects, and risk for eventual metastasis of the cancer. Learning about patients' thoughts and reactions to informational resources may better support patients during ocular melanoma survivorship.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 108 (actual)
- First submitted
- 4 Oct 2023
- Start date
- 7 Nov 2023
- Primary completion date
- 14 Aug 2024
- Lead sponsor
- Jonsson Comprehensive Cancer Center
- Diseases
- Melanoma
- NCT number
- NCT06075589
What you commit to
- Study type: Interventional
- Participants enrolled: 108
- From 7 Nov 2023 to the primary completion date, 14 Aug 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \-
Who the study is looking for
- Adults (age 18 years and older at visit 1)
- History of uveal melanoma as documented in their University of California, Los Angeles (UCLA) medical record
- Receipt of uveal melanoma treatment and/or ongoing follow-up care at the UCLA Jules Stein Eye Institute, as documented in their UCLA medical record
- Ability to read, write, and converse in English
- Access to the internet via a computer or cell phone
- Access to a personal email address
- Written informed consent obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of California at Los Angeles Coordinator of this site? Confirm its status | Los Angeles | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.